Last edition
News about "JN.1 vaccine "
Novavax Submits Application to FDA for Updated JN.1 COVID-19 Vaccine
Novavax, Inc. has submitted an amendment to its Emergency Use Authorization to the US Food and Drug Administration (FDA) for its updated JN.1 COVID-19 vaccine (NVX-CoV2705) for individuals aged 12 and older.
JN.1 Vaccine | 15/06/2024 | By Aishwarya | 117
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members